Primary |
Pain |
42.2% |
Back Pain |
9.8% |
Drug Use For Unknown Indication |
9.8% |
Product Used For Unknown Indication |
6.4% |
Suicide Attempt |
5.4% |
Procedural Pain |
3.9% |
Cardiac Disorder |
2.9% |
Blood Pressure Increased |
2.0% |
Diabetes Mellitus |
2.0% |
Migraine |
2.0% |
Osteoarthritis |
2.0% |
Overdose |
2.0% |
Fibromyalgia |
1.5% |
Headache |
1.5% |
Hypertension |
1.5% |
Pain Management |
1.5% |
Abdominal Discomfort |
1.0% |
Analgesic Effect |
1.0% |
Anxiety |
1.0% |
Breakthrough Pain |
1.0% |
|
Drug Ineffective |
19.1% |
Completed Suicide |
8.2% |
Therapeutic Response Unexpected With Drug Substitution |
7.3% |
Vomiting |
7.3% |
Rash |
6.4% |
Respiratory Arrest |
5.5% |
Drug Toxicity |
4.5% |
Product Substitution Issue |
4.5% |
Constipation |
3.6% |
Intentional Drug Misuse |
3.6% |
Product Quality Issue |
3.6% |
Urticaria |
3.6% |
Withdrawal Syndrome |
3.6% |
Fall |
2.7% |
Medication Error |
2.7% |
Mental Status Changes |
2.7% |
Pruritus |
2.7% |
Sedation |
2.7% |
Somnolence |
2.7% |
Wrong Drug Administered |
2.7% |
|
Secondary |
Drug Use For Unknown Indication |
41.8% |
Product Used For Unknown Indication |
17.7% |
Pain |
16.3% |
Back Pain |
3.4% |
Ill-defined Disorder |
2.8% |
Suicide Attempt |
2.8% |
Cardiac Disorder |
1.6% |
Completed Suicide |
1.6% |
Suicidal Ideation |
1.4% |
Arthralgia |
1.2% |
Breakthrough Pain |
1.2% |
Depression |
1.2% |
Intentional Drug Misuse |
1.2% |
Type 2 Diabetes Mellitus |
1.2% |
Diabetes Mellitus |
0.8% |
Drug Abuse |
0.8% |
Injury |
0.8% |
Muscle Spasms |
0.8% |
Road Traffic Accident |
0.8% |
Anxiety |
0.6% |
|
Completed Suicide |
22.6% |
Respiratory Arrest |
18.2% |
Intentional Drug Misuse |
8.0% |
Overdose |
5.1% |
Cardio-respiratory Arrest |
4.4% |
Toxicity To Various Agents |
4.4% |
Accidental Overdose |
3.6% |
Death |
3.6% |
Drug Abuse |
3.6% |
Unresponsive To Stimuli |
3.6% |
Vomiting |
3.6% |
Renal Failure Acute |
2.9% |
Drug Administration Error |
2.2% |
Drug Ineffective |
2.2% |
Drug Toxicity |
2.2% |
Product Quality Issue |
2.2% |
Sedation |
2.2% |
Somnolence |
2.2% |
Alopecia |
1.5% |
Drug Effect Decreased |
1.5% |
|
Concomitant |
Product Used For Unknown Indication |
26.9% |
Drug Use For Unknown Indication |
19.6% |
Pain |
12.4% |
Depression |
4.7% |
Hypertension |
4.4% |
Back Pain |
3.0% |
Osteoporosis |
3.0% |
Anxiety |
2.8% |
Restless Legs Syndrome |
2.5% |
Insomnia |
2.4% |
Smoking Cessation Therapy |
2.3% |
Rheumatoid Arthritis |
2.2% |
Type 2 Diabetes Mellitus |
2.2% |
Diabetes Mellitus |
1.9% |
Contraception |
1.8% |
Sleep Disorder |
1.8% |
Blood Cholesterol Increased |
1.7% |
Diffuse Large B-cell Lymphoma |
1.5% |
Gastrooesophageal Reflux Disease |
1.4% |
Affective Disorder |
1.3% |
|
Weight Decreased |
17.2% |
Urinary Tract Infection |
8.3% |
Death |
5.7% |
Pain |
5.7% |
Nausea |
5.1% |
Swelling Face |
5.1% |
Type 2 Diabetes Mellitus |
5.1% |
Vomiting |
5.1% |
Vision Blurred |
4.5% |
Dyspnoea |
3.8% |
Injury |
3.8% |
Pain In Extremity |
3.8% |
Pulmonary Embolism |
3.8% |
X-ray |
3.8% |
Anxiety |
3.2% |
Loss Of Consciousness |
3.2% |
Rash |
3.2% |
Tooth Extraction |
3.2% |
Walking Disability |
3.2% |
Weight Increased |
3.2% |
|